Barbiturates are a class of sedative drugs that slow brain activity, and today they’re used primarily for three things: controlling seizures, inducing anesthesia, and treating severe tension headaches. While they were once the go-to prescription for anxiety and insomnia, those roles have largely been taken over by safer alternatives. Barbiturates remain in use where their powerful sedative effects are specifically needed and no better option exists.
How Barbiturates Work in the Brain
Barbiturates enhance the activity of a natural brain chemical called GABA, which acts like a brake on nerve signaling. When GABA binds to its receptor, it opens a channel that lets negatively charged particles flow into the nerve cell, making it harder to fire. Barbiturates bind to a different spot on the same receptor and amplify this calming effect.
What makes barbiturates unusual is that at low concentrations they boost GABA’s natural braking action, but at higher concentrations they can open those channels entirely on their own, without GABA present at all. This is a key reason barbiturates are so potent, and so dangerous in overdose. Taking roughly ten times the therapeutic dose can cause fatal suppression of breathing or heart function. Benzodiazepines, which replaced barbiturates for most uses, cannot force those channels open independently. That difference gives benzodiazepines a much wider margin of safety.
Seizure Control
Phenobarbital, a long-acting barbiturate, is one of the oldest anticonvulsant medications still in clinical use. It remains a reliable option for managing epilepsy, particularly in parts of the world where newer drugs are expensive or unavailable. In the United States, it’s less commonly a first choice for routine epilepsy, but it still plays a role in emergencies.
For status epilepticus (a seizure lasting longer than five minutes or repeated seizures without recovery between them), current guidelines from the American Epilepsy Society list phenobarbital as a reasonable alternative during the second treatment phase, roughly 20 to 40 minutes into seizure activity, if preferred options aren’t available or haven’t worked. It sits behind three other medications in the recommended hierarchy, largely because of its side effects, but it remains a critical backup when other treatments fail.
Anesthesia
Ultra-short-acting barbiturates like methohexital and thiopental are used to induce general anesthesia. These drugs take effect within seconds when given intravenously, producing unconsciousness almost immediately. Their effects also wear off quickly, which makes them useful for the brief window needed to transition a patient onto inhaled anesthetics or other agents that maintain unconsciousness during surgery. Methohexital is also commonly used for short procedures like electroconvulsive therapy, where a patient needs to be unconscious for only a few minutes.
Tension Headache Treatment
One of the more common ways people encounter barbiturates today is through combination headache medications. Butalbital, an intermediate-acting barbiturate, is combined with acetaminophen and caffeine in prescription products used to relieve tension headaches. The butalbital relaxes the central nervous system while the other ingredients address pain and help with absorption. These prescriptions are widely used but typically limited to occasional headaches rather than daily use, because regular use can lead to dependence and rebound headaches.
Medically Induced Coma
In intensive care settings, high-dose barbiturates are sometimes used to induce a deep coma in patients with severe traumatic brain injuries. The goal is to reduce dangerously elevated pressure inside the skull when every other medical and surgical option has failed. The Brain Trauma Foundation recommends this approach only as a last resort, and only when the patient’s blood pressure can be kept stable throughout. Barbiturate coma is not used preventively: guidelines specifically advise against giving barbiturates prophylactically to brain injury patients, because the risks (including severe drops in blood pressure) outweigh the benefits unless pressure is already uncontrollable.
Veterinary Medicine
Barbiturates are widely used in veterinary practice, most notably for humane euthanasia. Pentobarbital, given by injection, is the standard method for euthanasia across nearly every type of animal, from dogs and cats to horses, cattle, fish, marine mammals, and rodents. The Merck Veterinary Manual lists injected barbiturates as an acceptable sole method of euthanasia for virtually every species. The drug produces rapid unconsciousness followed by cessation of breathing and heart function, and it is considered the benchmark for humane endpoints in veterinary care.
Why Barbiturates Are Rarely Prescribed Today
For most of the mid-20th century, barbiturates were the primary treatment for anxiety, insomnia, and a range of other conditions. That changed when benzodiazepines arrived in the 1960s and proved far safer. Benzodiazepines develop tolerance more slowly, carry a lower risk of fatal overdose, and have less potential for abuse. As a result, barbiturates lost nearly all of their former indications.
The narrow gap between a therapeutic dose and a lethal dose is the central problem. A person taking barbiturates for sleep can accidentally reach a dangerous dose by taking just a few extra pills, especially if alcohol is involved. This slim margin, combined with high dependence potential, means barbiturates are now reserved for situations where their specific pharmacological properties are genuinely irreplaceable.
Dependence and Withdrawal Risks
Barbiturates produce physical dependence relatively quickly with regular use. Withdrawal symptoms can begin as soon as 12 to 16 hours after the last dose for shorter-acting drugs, and they typically peak within one to three days. Longer-acting barbiturates may delay the onset of withdrawal by several days.
The withdrawal itself can be severe and medically dangerous. Early symptoms include anxiety, restlessness, nausea, and vomiting. As withdrawal progresses, people may experience abdominal cramps, rapid heart rate, visible tremors, involuntary muscle jerks, and generalized seizures. Barbiturate withdrawal falls into the same risk category as alcohol withdrawal: both can be life-threatening without medical supervision. Stopping barbiturates abruptly after prolonged use is never safe to do on your own.
Types of Barbiturates by Duration
Barbiturates are grouped into four categories based on how quickly they act and how long their effects last. This classification determines which medical situations each drug is suited for.
- Ultra-short-acting (seconds to minutes): used for anesthesia induction. Examples include methohexital and thiopental.
- Short-acting (minutes to hours): pentobarbital and secobarbital. Pentobarbital is widely used in veterinary euthanasia.
- Intermediate-acting (hours): butalbital (found in headache medications) and amobarbital.
- Long-acting (many hours to days): phenobarbital, the primary barbiturate used for seizure disorders.
The shorter the duration, the faster the onset. Ultra-short-acting barbiturates reach the brain almost instantly when injected, while phenobarbital takes longer to peak but provides sustained anticonvulsant activity, which is exactly what’s needed for ongoing seizure management.